---
title: "AHWB released its first-quarter performance, with a net profit attributable to the parent company of 11.8493 million yuan, a decrease of 60.09%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236783715.md"
description: "AHWB released its Q1 2025 performance report, with operating revenue of 71.0522 million yuan, a year-on-year decrease of 21.20%; net profit attributable to the parent company of 11.8493 million yuan, a year-on-year decline of 60.09%; net profit after deducting non-recurring gains and losses of 5.3589 million yuan, a year-on-year decrease of 76.44%; basic earnings per share of 0.18 yuan"
datetime: "2025-04-21T11:51:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236783715.md)
  - [en](https://longbridge.com/en/news/236783715.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236783715.md)
generator: "portal-rs"
---

# AHWB released its first-quarter performance, with a net profit attributable to the parent company of 11.8493 million yuan, a decrease of 60.09%

According to the Zhitong Finance APP, AHWB (301520.SZ) released its first-quarter report for 2025, with operating revenue of 71.0522 million yuan, a year-on-year decrease of 21.20%. The net profit attributable to shareholders of the listed company was 11.8493 million yuan, a year-on-year decrease of 60.09%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 5.3589 million yuan, a year-on-year decrease of 76.44%. The basic earnings per share were 0.18 yuan

### Related Stocks

- [301520.CN](https://longbridge.com/en/quote/301520.CN.md)

## Related News & Research

- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)
- [Kelun-Biotech: Buy Rating Reaffirmed as Strong sac-TMT Momentum Drives Target Price Increase from HK$507.11 to HK$642.29](https://longbridge.com/en/news/296393818.md)
- [Standard Uranium flags 55 meters of uranium enrichment at Corvo project in Saskatchewan](https://longbridge.com/en/news/296483204.md)
- [Rein Therapeutics releases corporate presentation on LTI-03 idiopathic pulmonary fibrosis program](https://longbridge.com/en/news/296389731.md)
- [07:55 ETSAPPHIRE LENSES & WINDOWS PROTECT SENSITIVE ELECTRO-OPTICAL SYSTEMS](https://longbridge.com/en/news/296224371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**